Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

Mater Sociomed. 2010; 22(2): 85-89

Lamotrigine in the Epilepsy Therapy at the Sarajevo Neurology Clinic

Azra Alajbegovic, Salem Alajbegovic, Ljubica Todorovic.

Introduction: New antiepileptic drugs have opened a new era of therapy in the epilepsy treatment. The aim of this paper is to establish a therapeutic effect of the new antiepileptic (AE) as a supplement therapy in the treatment of those types of epilepsy which proved to be resistant to previously used therapy, with a special emphasis on lamotrigine. Aim: To prove the efficacy of new antiepileptics as an additional therapy in treating those forms of epileptic seizures which had proved resistant to previously used therapy. Material and methods: The research was undertaken at the Sarajevo Neurology Clinic. It included 60 epileptic patients (30 patients with the old antiepileptic therapy, 30 with the new antiepileptics as add on). All patients had partial epileptic fits with secondary generalizations. Results: The male female ratio in both groups was the same 16M:14F. 33% of patients were under 20, mean age was 27.2 years. The most frequent antiepileptic therapy was the combination of carbamazepine and lamotrigine in 67% of patients in the group with the new AE, while 90% of patients in the group with the old AE received carbamazepine. Conclusion: New antiepileptics have proven to be efficient as a supplement therapy in the treatment of previously resistant epileptic fits. The frequency of fits was reduced in 66.7% of patients, and in 16.7% of patients the fits were alleviated. The new AE did not significantly influence the psychological traits of patients; in all patients an improved quality of life was noted after introducing the new lamotrigine to the therapy.

Key words: epilepsy, new antiepileptics , therapeutic effect.

Share this Article

Journal of Molecular Pathophysiology


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.